April 2026
April 2026 | Global Perspectives
Vigabatrin-Related Retinal Toxicity
Patients taking this medication for epilepsy should be monitored carefully for visual disturbances.
Natalia Londoño De Vivero, MD; Rafael Méndez Marulanda, MD; Daniela Rojas Pérez, MD; Clemencia De Vivero Arciniegas, MD; and Álvaro Mejía Vergara, MD
April 2026 | Features
The Value of OCTA in Retinal Vascular Disease
Measuring retinal blood flow is easier than ever before, with new tools under investigation to further improve our ability to assess changes in the retinal vasculature.
Sarah Aman, MD; Viet-Hoan Le, PhD; Ruikang K. Wang, PhD; and Amir H. Kashani, MD, PhD
Popular Articles
March 2026 Insert | One To Watch
One to Watch: Archana A. Nair, MD, MS
Archana A. Nair, MD, MS
April 2026 Insert
One to Watch: Samir N. Patel, MD
Samir N. Patel, MD
March 2026 Supplement | Digital Supplement
Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease
November/December 2025 Supplement
Preserving Vision in Macular Telangiectasia Type 2
Jay Chhablani, MD, and Lihteh Wu, MD